Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2015 Jul;24(7):1121-9.
doi: 10.1158/1055-9965.EPI-14-0317. Epub 2015 Apr 2.

Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci

Ali Amin Al Olama  1 Sara Benlloch  2 Antonis C Antoniou  2 Graham G Giles  3 Gianluca Severi  4 David E Neal  5 Freddie C Hamdy  6 Jenny L Donovan  7 Kenneth Muir  8 Johanna Schleutker  9 Brian E Henderson  10 Christopher A Haiman  10 Fredrick R Schumacher  10 Nora Pashayan  11 Paul D P Pharoah  2 Elaine A Ostrander  12 Janet L Stanford  13 Jyotsna Batra  14 Judith A Clements  14 Suzanne K Chambers  15 Maren Weischer  16 Børge G Nordestgaard  16 Sue A Ingles  10 Karina D Sorensen  17 Torben F Orntoft  17 Jong Y Park  18 Cezary Cybulski  19 Christiane Maier  20 Thilo Doerk  21 Joanne L Dickinson  22 Lisa Cannon-Albright  23 Hermann Brenner  24 Timothy R Rebbeck  25 Charnita Zeigler-Johnson  26 Tomonori Habuchi  27 Stephen N Thibodeau  28 Kathleen A Cooney  29 Pierre O Chappuis  30 Pierre Hutter  31 Radka P Kaneva  32 William D Foulkes  33 Maurice P Zeegers  34 Yong-Jie Lu  35 Hong-Wei Zhang  36 Robert Stephenson  37 Angela Cox  38 Melissa C Southey  39 Amanda B Spurdle  40 Liesel FitzGerald  41 Daniel Leongamornlert  42 Edward Saunders  42 Malgorzata Tymrakiewicz  42 Michelle Guy  42 Tokhir Dadaev  42 Sarah J Little  42 Koveela Govindasami  42 Emma Sawyer  42 Rosemary Wilkinson  42 Kathleen Herkommer  43 John L Hopper  44 Aritaya Lophatonanon  45 Antje E Rinckleb  20 Zsofia Kote-Jarai  42 Rosalind A EelesDouglas F Easton  1 UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of OncologyUK ProtecT Study CollaboratorsPRACTICAL Consortium
Collaborators, Affiliations
Multicenter Study

Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci

Ali Amin Al Olama et al. Cancer Epidemiol Biomarkers Prev. 2015 Jul.

Abstract

Background: Genome-wide association studies have identified multiple genetic variants associated with prostate cancer risk which explain a substantial proportion of familial relative risk. These variants can be used to stratify individuals by their risk of prostate cancer.

Methods: We genotyped 25 prostate cancer susceptibility loci in 40,414 individuals and derived a polygenic risk score (PRS). We estimated empirical odds ratios (OR) for prostate cancer associated with different risk strata defined by PRS and derived age-specific absolute risks of developing prostate cancer by PRS stratum and family history.

Results: The prostate cancer risk for men in the top 1% of the PRS distribution was 30.6 (95% CI, 16.4-57.3) fold compared with men in the bottom 1%, and 4.2 (95% CI, 3.2-5.5) fold compared with the median risk. The absolute risk of prostate cancer by age of 85 years was 65.8% for a man with family history in the top 1% of the PRS distribution, compared with 3.7% for a man in the bottom 1%. The PRS was only weakly correlated with serum PSA level (correlation = 0.09).

Conclusions: Risk profiling can identify men at substantially increased or reduced risk of prostate cancer. The effect size, measured by OR per unit PRS, was higher in men at younger ages and in men with family history of prostate cancer. Incorporating additional newly identified loci into a PRS should improve the predictive value of risk profiles.

Impact: We demonstrate that the risk profiling based on SNPs can identify men at substantially increased or reduced risk that could have useful implications for targeted prevention and screening programs.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: There is no conflict of interest.

Figures

Figure 1
Figure 1
Absolute risk of PrCa by age in men with family history.
Figure 2
Figure 2
Absolute risk of PrCa by age in men with no family history.

Comment in

References

    1. Pashayan N, Duffy SW, Chowdhury S, Dent T, Burton H, Neal DE, et al. Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. Br J Cancer. 2011;104:1656–1663. - PMC - PubMed
    1. Amin Al Olama A, Kote-Jarai Z, Giles GG, Guy M, Morrison J, Severi G, et al. Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet. 2009;41:1058–1060. - PubMed
    1. Eeles RA, Kote-Jarai Z, Amin Al Olama A, Giles GG, Guy M, Severi G, et al. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet. 2009;41:1116–1121. - PMC - PubMed
    1. Eeles RA, Kote-Jarai Z, Giles GG, Amin Al Olama A, Guy M, Jugurnauth SK, et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet. 2008;40:316–321. - PubMed
    1. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, et al. A common variant associated with prostate cancer in European and African populations. Nat Genet. 2006;38:652–658. - PubMed

Publication types